Ligand validation:7JNZ

VGV: N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)cyclohexanecarboxamide

VGV is a Ligand Of Interest in 7JNZ designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7JNZ_VGV_A_303	74%	1%	0.13	0.959	4.49	3.58	11	13	3	0	100%	1
7JOB_VGV_A_302	79%	1%	0.117	0.963	4.45	4.04	11	14	2	0	100%	1
8DQF_VGV_C_301	74%	3%	0.146	0.976	2.63	3.37	6	10	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.